Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Theranos CEO Holmes on diagnostics, the FDA, and what’s wrong with lab oversight

October 27, 2015 By Heather Thompson

Theranos CEO Elizabeth HolmesElizabeth Holmes is the CEO of Theranos, a lab company dedicated to quickly processing a full range of laboratory tests from a few drops of blood, rather than numerous tubes, and at unprecedented low costs.

The technology is directly accessible to people and their physicians through Theranos Wellness Centers. Holmes has been an outspoken proponent of making lab tests affordable and accessible to patients.

Theranos recently came under fire from articles in the Wall Street Journal. Last week, in Laguna Beach, Calif., the Journal held its live event, with Holmes speaking to global technology editor Jonathan Krim to set the record straight. You can watch the entire interview through AACentral.com.

During the event, Holmes told Krim that the Journal misrepresented the company’s plans to switch from a CLIA framework to an FDA framework, as well as mischaracterized the FDA’s QSR inspection as evidence that the company’s testing platform was under question by the agency. The assumptions made by the news outlet, she said, are untrue. The FDA today released its report on the inspections, flagging quality issues at a manufacturing plant in Newark, Calif., after inspections in August and September.

The event demonstrates how difficult it can be to educate media about diagnostic testing, not to mention FDA processes. I laughed out loud when the interviewer asked pointedly about the FDA’s “surprise” inspection, as though a surprise quality review from the agency is unusual. In fact, FDA’s QSR inspections are almost always conducted without forewarning, to the point at which there are educational classes on how to be ready, even when you’re not ready.

Throughout the conversation, Holmes was brilliant. She was calm, and clear about Theranos’s product platform, its ethos as a company, and its dedication to providing accurate data.

In addition, Theranos has published a rebuttal to the original Journal articles, saying that it believes the future of clinical labs should be in the hands of the FDA.

“We believe the model for the lab of the future is to take all tests through FDA review,” Theranos said.

Related Articles Read More >

Kahle Automation's new logo, including the logo of its new owner, BBS Automation
BBS Automation has a deal to buy medtech supplier Kahle Automation
A portrait of Dexcom VP of Global Clinical Initiatives Tomas Walker
Dexcom focuses on early diabetes diagnosis as COVID links emerge
Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
A portrait of ResMed executive Lucile Blaise
ResMed names Lucile Blaise as new Sleep & Respiratory Care leader

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech